Urgent

Bradyarrhythmias & supraventricular/ventricular tachyarrhythmias

Cardiology · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Treat the patient, not just the rhythm: assess for adverse features (shock, syncope, ischaemia, heart failure). Unstable tachyarrhythmias get synchronised cardioversion; unstable bradycardias get atropine then pacing.

Red flags

  • Admit any unstable or sustained arrhythmia, broad-complex tachycardia, high-grade AV block, or syncope with ECG abnormality
  • Refer cardiology/EP for recurrent SVT, VT, device candidacy, inherited arrhythmia syndromes or unexplained syncope with structural/ECG red flags

Assessment

Investigations

  • 12-lead ECG (capture during episode) and rhythm strip; ambulatory/loop monitor for intermittent symptoms
  • Bloods: U&E, Mg2+, Ca2+, TFTs, troponin, digoxin level, FBC
  • Echo for structural disease/scar
  • Electrophysiology study for mechanism/ablation
  • Review QT interval and offending drugs

Management

  • Follow Resuscitation Council algorithms
  • Tachycardia with adverse features: synchronised DC cardioversion (up to 3 shocks), then amiodarone 300 mg IV
  • Stable narrow regular SVT: vagal manoeuvres, then adenosine 6 mg then 12 mg IV (avoid in asthma/WPW-AF)
  • Stable broad- complex (VT): amiodarone 300 mg IV over 20-60 min; correct K+/Mg2+
  • Torsades: IV magnesium sulfate, stop QT-prolonging drugs, correct electrolytes
  • Bradycardia with adverse features: atropine 500 mcg IV (repeat to 3 mg), then transcutaneous pacing or isoprenaline/adrenaline infusion; transvenous/permanent pacing for high-grade AV block (Mobitz II, complete heart block)
  • Stop causative drugs

Disposition

Admit any unstable or sustained arrhythmia, broad-complex tachycardia, high-grade AV block, or syncope with ECG abnormality.

Complications & pitfalls

  • Haemodynamic collapse, syncope with injury, degeneration of VT/polymorphic VT into ventricular fibrillation and cardiac arrest/sudden death, asystole from high-grade AV block, tachycardia-induced cardiomyopathy, thromboembolism (atrial arrhythmias)

Exam pearls

  • A regular broad-complex tachycardia in a patient with known ischaemic heart disease is VT until proven otherwise — treating it as SVT with a verapamil can be fatal; if unstable, shock; if stable, amiodarone and correct Mg2+/K+.
  • Monitoring & follow-up: FOLLOW- Continuous cardiac monitoring in the acute phase. Review drug culprits and electrolytes. UP Arrange definitive therapy: ablation for recurrent SVT/VT, permanent pacemaker for symptomatic brady/high-grade block, ICD for sustained VT/VF or high sudden-death risk. Review QT-prolonging medication lists.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.